WHO WE ARE
GenenDesign was founded in 2007 with the dedication to build the largest cancer model platform for cancer research, drug discovery and patient treatment needs. We all share the vision of finding drug treatments for each cancer patient. We value good science, advanced technology and achievements in helping cancer patients. We practice our work with precision and persistence. Our two sites are located in Shanghai (China) and Menlo Park, California (USA).
WHAT WE BELIEVE
CANCER DRUGS: More effective drugs will be developed, but they should not be as expensive or toxic as many of them are today.
CANCER TREATMENT: There will be cures for each cancer patient. We just need to work hard to find the right drugs for the right patients.
HEALTH CARE INDUSTRY: The industry will shift from “developing drugs” to “choosing drugs” in the coming decade.
Company Details
- Employees
- 1
- Founded
- 2007
- Address
- Building #7, 501,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- genendesign.com
- Keywords
- Drug and diagnostics R&D service, Drug response prediction service, Medical science information services.
- HQ
- Shanghai
Genendesign Co., Ltd Questions
Genendesign Co., Ltd's website is genendesign.com
Genendesign Co., Ltd's LinkedIn profile is https://www.linkedin.com/company/genendesign-co--ltd
Genendesign Co., Ltd has
1 employees.
View email and phone details for 1
employees at Genendesign Co., Ltd.
Genendesign Co., Ltd's industry is
Biotechnology Research
Genendesign Co., Ltd's top competitors are
Flare Therapeutics,
Cullinan Therapeutics,
Quotient Therapeutics,
Regor Therapeutics Group,
Revolution Medicines.
Genendesign Co., Ltd's categories are Biotechnology Research
Genendesign Co., Ltd's founding year is 2007
